JEIL PHARMACEUTICAL CO., LTD.
π°π·South Korea
Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-07-10
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02186483
- Locations
- π°π·
Samsung Medical Center(SMC), Seoul, Gangnam-Gu, Korea, Republic of
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-07-03
- Last Posted Date
- 2016-06-24
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT02180997
- Locations
- π°π·
Seoul National University Hospital(SNUH), Seoul, Jongno-Gu, Korea, Republic of
The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers
- First Posted Date
- 2013-11-14
- Last Posted Date
- 2016-06-24
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT01983358
- Locations
- π°π·
Asan Medical Center, Seoul, Song-Pa Gu, Korea, Republic of
Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
- First Posted Date
- 2007-11-06
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT00553865
- Locations
- π°π·
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Β© Copyright 2024. All Rights Reserved by MedPath